KSS
51
8
MCHP
49
-3
PYPL
37
-4
CNP
67
4
CMI
65
3
NFLX
61
-8
HES
67
5
QCOM
72
-5
AEE
50
4
ZTS
54
5
RL
79
3
APA
21
-4
ROP
74
2
CHK
12
9
CINF
53
6
D
37
2
PX
62
14
AME
63
3
FLR
38
2
HOG
33
2
KSS
51
8
MCHP
49
-3
PYPL
37
-4
CNP
67
4
CMI
65
3
NFLX
61
-8
HES
67
5
QCOM
72
-5
AEE
50
4
ZTS
54
5
RL
79
3
APA
21
-4
ROP
74
2
CHK
12
9
CINF
53
6
D
37
2
PX
62
14
AME
63
3
FLR
38
2
HOG
33
2
Financhill
Back

Palisade Bio Vs. Cytokinetics Industry Stock Comparison

Sell
23

PALI
Palisade Bio

Last Price:
4.53
Seasonality Move:
-21.13%
Buy
52

CYTK
Cytokinetics

Last Price:
52.86
Seasonality Move:
5.69%
Sell
23
Palisade Bio (PALI) is a Sell

Is Palisade Bio a Buy, Sell or Hold?

  • The current Palisade Bio [PALI] share price is $4.62. The Score for PALI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PALI Stock Price Chart

What is Palisade Bio's stock price today?

  • The Palisade Bio share price today is $4.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

PALI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 41.19 Sell
Chaikin Money Flow: -3156 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.37 - 5.27) Sell
Bollinger Bands (100): (4.82 - 6.86) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 47.99 Sell
Chaikin Money Flow: 69998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.06 - 56.58) Buy
Bollinger Bands (100): (56.38 - 74.98) Sell

PALI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.61 Buy
20-day SMA: 4.62 Sell
50-day SMA: 5.54 Sell
200-day SMA: 7.3 Sell
8-day EMA: 4.63 Sell
20-day EMA: 4.82 Sell
50-day EMA: 5.33 Sell
200-day EMA: 18.52 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.08 Buy
20-day SMA: 51.6 Buy
50-day SMA: 58.73 Sell
200-day SMA: 55.73 Sell
8-day EMA: 53.02 Buy
20-day EMA: 53.6 Buy
50-day EMA: 57.71 Sell
200-day EMA: 56.9 Sell

Palisade Bio Earnings Growth & PALI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.47 per share, and an increase next year of $2.85 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.08 per share.

Palisade Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):